» Articles » PMID: 30777047

Hb Knossos (HBB: C.82G > T), β-globin CD 5 (-CT) (HBB: C.17_18delCT) and δ-globin CD 59 (-a) (HBD: C.179delA) Mutations in a Syrian Patient with β-thalassemia Intermedia

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2019 Feb 20
PMID 30777047
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Beta thalassemia (β-thal) is an inherited hemoglobin disorder characterized by reduced synthesis of the hemoglobin that results in microcytic hypochromic anemia. β-Thalassemia intermedia (TI) is a clinical term of intermediate gravity between the carrier state and β-thalassemia major (β -TM).

Case Presentation: We describe a 12-year-old male proband originating from Al-Quneitra province - southwest Syria. Hematological investigations revealed, pallor and anemia (Hb 9 g/dl). The mean cell volume (MCV) 64 fL; mean cell hemoglobin (MCH) 21.8 pg. Capillary electrophoresis (CE) electropherogram revealed low level of Hb A1 (36.2%), high level of Hb F (62.2%) and low level of Hb A2 (1.6%). The proband requires blood transfusion occasionally. Direct DNA sequencing and Polymerase chain reaction-restriction fragment length polymorphism (PCR/RFLP) for mutations detection were used. The molecular analysis revealed the presence of rare β Hb Knossos codon 27 (G > T) (HBB: c.82G > T) variant associated with β codon 5 [-CT] (HBB: c.17_18delCT) mutation in beta-globin (β-globin) gene and δ codon 59 [-A] (HBD: c.179delA) mutation in delta-globin (δ-globin) gene. The proband tested negative for the common deletional forms of alpha thalassemia (α-thal). Polymorphism of the Xmn-I locus (HBG2: c.-211C > T) revealed that the proband had a homozygous [TT] for Xmn-1 locus.

Conclusions: To our knowledge, this is the first report of beta thalassemia intermedia due to combination of Hb Knossos /codon 5 [-CT] associated with δ codon 59 [-A] in Syrian patient. On the other hand, in Syria, β-thal carriers who have low level of Hb A2 due to decreased δ-chain production, different δ-thal gene mutations must be screened to avoid the failure diagnosis of β-thal disease.

Citing Articles

Performance Evaluation of the DxC 700 AU Chemistry Analyzer in Hemoglobin A1c Measurement.

Choi Y, Kang H, Cho C, Rim J, Lee S, Lim J Ann Lab Med. 2022; 43(2):167-173.

PMID: 36281510 PMC: 9618898. DOI: 10.3343/alm.2023.43.2.167.

References
1.
Gurgey A, Balkan H, Irken G, Gumruk F, Altay S, Kalaycioglu A . Compound heterozygosity for hemoglobin Knossos [alpha 2 beta 2 27 (B9) Ala-Ser] and IVS I-1 mutation. Turk J Pediatr. 1997; 39(2):253-7. View

2.
FESSAS P, Loukopoulos D, Loutradi-Anagnostou A, Komis G . 'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia. Br J Haematol. 1982; 51(4):577-83. DOI: 10.1111/j.1365-2141.1982.tb02821.x. View

3.
Nasouhipur H, Banihashemi A, Kamangar R, Akhavan-Niaki H . Hb Knossos: HBB:c.82G>T Associated with HBB:c.315+1G>A Beta Zero Mutation Causes Thalassemia Intermedia. Indian J Hematol Blood Transfus. 2014; 30(Suppl 1):243-5. PMC: 4192188. DOI: 10.1007/s12288-014-0343-y. View

4.
Galanello R, Origa R . Beta-thalassemia. Orphanet J Rare Dis. 2010; 5:11. PMC: 2893117. DOI: 10.1186/1750-1172-5-11. View

5.
Liu N, Xie X, Zhou J, Li R, Liao C, Li D . Analysis of δ-globin gene mutations in the Chinese population. Hemoglobin. 2012; 37(1):85-93. DOI: 10.3109/03630269.2012.747965. View